EGFR T790M detection in TKI-naive NSCLCs carrying sensitive EGFR mutations

被引：0
|
作者：
Pinotti, G. [1 ]
Cerutti, R. [2 ]
Sahnane, N. [2 ]
Lettig, L. [2 ]
Albeni, C. [2 ]
Tuzi, A. [1 ]
Franzi, F. [2 ]
Pastore, A. [1 ]
Ogliari, F. [1 ]
Sessa, F. [2 ]
Furlan, D. [2 ]
机构：
[1] Osped Circolo Varese, Oncol, Fdn Macchi, Varese, Italy
[2] Univ Insubria, Osped Circolo, Dept Med & Surg, Varese, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1335P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] In silico insight into EGFR treatment in patients with lung carcinoma and T790M mutations
    Zang, Shu-Zhi
    Yang, Yan-Rong
    Zhao, Sha-Sha
    Li, Yun-Xia
    Gao, Xin-Yuan
    Zhong, Chun-Lei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (05) : 1735 - 1740
  • [42] T790M MUTATION ASSOCIATED WITH BETTER EFFICACY OF CONTINUOUS EGFR-TKI TREATMENT IN ADVANCED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Ren, Shengxiang
    Li, Wei
    Li, Aiwu
    Chen, Xiaoxia
    Gao, Guanghui
    He, Yayi
    Li, Xuefei
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1084 - S1084
  • [43] Tissue Is the Issue for Diagnosis of EGFR T790M Mutation
    Khan, Jenna
    Pritchard, Colin C.
    Martins, Renato G.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : E91 - E92
  • [44] Monitoring of EGFR Mutations During Osimertinib Treatment in Advance EGFR-Mutant T790M Positive NSCLC
    Mohorcic, K.
    Janzic, A.
    Janzic, U.
    Rot, M.
    Kern, I.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S557 - S558
  • [45] Osimertinib for EGFR-Mutant NSCLC Patients With Acquired T790M and EGFR Amplification After First-Generation EGFR-TKI Resistance
    Zhang, Yidan
    Xu, Yingqi
    Xu, Jianlin
    Zhong, Hua
    Xia, Jinjing
    Zhong, Runbo
    CANCER SCIENCE, 2024,
  • [46] EGFR T790M co-exists with sensitive mutations in the same cell group in lung adenocarcinoma patients
    Shi, X.
    Wu, S.
    Wang, H.
    Liang, Z.
    Zeng, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S92 - S92
  • [47] Detection of EGFR/T790M Mutation in Advanced NSCLC Post TKI Treatment: First Experience of Liquid Biopsy in Argentina
    Mosqueira, M. C.
    Anchordoqui, S.
    Martinez Correa, R.
    Pichelbauer, E.
    Trinchero, A.
    Bianchini, M.
    Bravo, I.
    Bramuglia, G.
    Diaz Perez, I.
    Sganga, L.
    Goncalves, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S166 - S167
  • [48] Osimertinib Depletes EGFR T790M in the Spinal Fluid of Patients with Carcinomatous Meningitis of Lung Adenocarcinoma Harboring De Novo EGFR T790M
    Senoo, Satoru
    Ohashi, Kadoaki
    Nishii, Kazuya
    Hara, Naofumi
    Kano, Hirohisa
    Ninomiya, Kiichiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : E140 - E142
  • [49] Highly sensitive and quantitative detection of EGFR T790M mutationin tumor samples by nanofluidic digital PCR
    Iwama, Eiji
    Takayama, Koichi
    Harada, Taishi
    Okamoto, Isamu
    Baba, Eishi
    Oda, Yoshinao
    Nakanishi, Yoichi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Correlation between re-biopsy site and detection of T790M mutation in NSCLC patients treated with EGFR TKI
    Shigematsu, Fumie
    Kogure, Yoshihito
    Saka, Hideo
    Yamada, Arisa
    Ishida, Akane
    Ise, Yuko
    Hori, Kazumi
    Oka, Saori
    Nakahata, Masashi
    Kitagawa, Chiyoe
    Oki, Masahide
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345